Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Heal... Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19). Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.13 | 5.93607305936 | 2.19 | 2.39 | 2.1428 | 16350 | 2.29262722 | CS |
| 4 | 0.05 | 2.20264317181 | 2.27 | 2.595 | 2.1 | 30947 | 2.32843283 | CS |
| 12 | -0.71 | -23.4323432343 | 3.03 | 3.682766 | 2.03 | 251170 | 2.6074321 | CS |
| 26 | -1.11 | -32.361516035 | 3.43 | 4.87 | 2.03 | 170972 | 3.13709298 | CS |
| 52 | -9.664 | -80.6408544726 | 11.984 | 14.9152 | 1.8301 | 1428015 | 7.10539628 | CS |
| 156 | -163.28 | -98.5990338164 | 165.6 | 239.976 | 1.8301 | 862616 | 18.48348064 | CS |
| 260 | -508.88 | -99.5461658842 | 511.2 | 883.2 | 1.8301 | 1066586 | 204.82073835 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
